KZR / Kezar Life Sciences, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Kezar Life Sciences, Inc.

Deler fremragende 7,387,701 shares
Insideraktier1.489.510 shares
Insider ejerskab20,16 %
Total Insiders40
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
4765 out of 10986

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
4761 out of 10856

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Kezar Life Sciences, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
A.M. Pappas Life Science Ventures V, LP 10% Owner - [10%] 23.894 2.389
Amgen Inc 10% Owner - [10%] 1.121.384 112.138
AMP&A Management V, LLC 10% Owner - [10%] 23.894 2.389
Aberdare Management Company, LLC 10% Owner - [10%] 136.643 13.664
Bay City Capital Llc 10% Owner - [10%] 622.229 62.223
Franklin M Berger Director - [D] 890.691 89.069
Marc Belsky CFO - [O] 15.384 1.538
Graham K Cooper 26.000
Bihua Chen Director, 10% Owner - [D] [10%] 1.572.909 157.291
Pichi Luo Chiang SVP, Corporate Controller - [O] 2.711 2.711
Giacomo Chiesi 10% Owner - [10%] 314.819 31.482
Chiesi Ventures, Inc. 10% Owner - [10%] 314.819 31.482
Chiesi Ventures, LP 10% Owner - [10%] 314.819 31.482
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Cormorant Asset Management, LLC 10% Owner - [10%] 1.572.909 157.291
Cormorant Global Healthcare GP, LLC 10% Owner - [10%] 1.572.909 157.291
Cormorant Global Healthcare Master Fund, LP 10% Owner - [10%] 1.572.909 157.291
Jason Dinges 8.896
Vassiliki Economides SVP, Strategy & External Aff. - [O] 11.320 1.132
Equal Talent Investments Ltd 10% Owner - [10%] 6.254.545 625.454
John Franklin Fowler CEO, Director - [D] [O] 436.115 43.612
Elizabeth Garner 8.896
Niti Goel 75.000
Noreen Henig 180.000
Michael Kauffman Director - [D] 63.690 6.369
Kirk Christopher J. Director - [D] 431.348 43.135
Lim Richard J. 10% Owner - [10%] 693.272 69.327
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Morningside Venture Investments Ltd 10% Owner - [10%] 1.947.993 194.799
Omega Fund IV G.P. Manager, Ltd. 10% Owner - [10%] 693.272 69.327
Omega Fund IV GP, L.P. 10% Owner - [10%] 693.272 69.327
Omega Fund IV, L.P. - 693.272 69.327
Onyx Therapeutics, Inc. 10% Owner - [10%] 1.121.384 112.138
Arthur M Pappas 10% Owner - [10%] 23.894 2.389
Pappas Capital, Llc 10% Owner - [10%] 23.894 2.389
PV V CEO Fund, LP 10% Owner - [10%] 23.894 2.389
Anne-Mari Paster 10% Owner - [10%] 693.272 69.327
Thomas F Steyer - 125.927 12.593
Schiller Mark C. Chief Operating Officer - [O] 2.739 2.739
Jean-Pierre Sommadossi Director - [D] 178.440 17.844
Otello Stampacchia 10% Owner - [10%] 693.272 69.327
Courtney Wallace 52.000

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i KZR / Kezar Life Sciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-03-21 BERGER FRANKLIN M 20.000 14,7700 2.000 147,7000 295.400 3 18.3300 -258.740 -87,59
2022-03-18 BERGER FRANKLIN M 15.000 15,9600 1.500 159,6000 239.400
2022-03-18 BERGER FRANKLIN M 45.000 17,0000 4.500 170,0000 765.000
2020-06-11 BERGER FRANKLIN M 100.000 5,5000 10.000 55,0000 550.000
2020-06-11 Equal Talent Investments Ltd 1.454.545 5,5000 145.454 55,0000 7.999.998
2020-02-04 Economides Vassiliki 5.769 2,6000 577 26,0000 14.999
2020-02-04 Morningside Venture Investments Ltd 3.800.000 2,6000 380.000 26,0000 9.880.000
2020-02-04 Belsky Marc 15.384 2,6000 1.538 26,0000 39.998
2020-02-04 BERGER FRANKLIN M 120.846 2,6000 12.085 26,0000 314.200

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

KZR / Kezar Life Sciences, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i KZR / Kezar Life Sciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-07-02 Schiller Mark C. 561 4,2800 561 4,2800 2.401 89 3.5900 -387 -16,12
2025-07-02 Chiang Pichi Luo 264 4,2800 264 4,2800 1.130
2024-07-02 Schiller Mark C. 6.688 0,5800 669 5,8000 3.879
2023-02-06 Morningside Venture Investments Ltd 40.000 6,8830 4.000 68,8300 275.320
2023-02-03 Morningside Venture Investments Ltd 25.000 7,1460 2.500 71,4600 178.650
2023-02-02 Morningside Venture Investments Ltd 50.000 7,1900 5.000 71,9000 359.500
2023-02-01 Morningside Venture Investments Ltd 40.000 6,9500 4.000 69,5000 278.000
2023-01-31 Morningside Venture Investments Ltd 30.000 7,0800 3.000 70,8000 212.400
2023-01-30 Morningside Venture Investments Ltd 30.000 6,9100 3.000 69,1000 207.300

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

KZR / Kezar Life Sciences, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2025-07-03 2025-07-02 4 Chiang Pichi Luo KZR Common Stock S - Sale D 4,2800 -264 -1 2.711
2025-07-03 2025-07-02 4 Schiller Mark C. KZR Common Stock S - Sale D 4,2800 -561 -2 2.739
2025-04-16 3 Chiang Pichi Luo KZR Common Stock D 2.975
2024-07-26 2024-07-02 4 Schiller Mark C. KZR Common Stock S - Sale D 0,5800 -6.688 -4 33.007
2024-01-17 3 Schiller Mark C. KZR Common Stock D 39.695
2023-08-17 2023-08-15 4 Morningside Venture Investments Ltd KZR Common Stock G - Gift D -3.500.000 1.947.993
2023-07-24 2023-07-20 4 Kirk Christopher J. KZR Common Stock M - Exercise D 0,9000 48.950 44 431.348
2023-02-07 2023-02-06 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 6,8830 -40.000 -275 5.447.993
2023-02-07 2023-02-03 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 7,1460 -25.000 -179 5.487.993
2023-02-03 2023-02-02 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 7,1900 -50.000 -360 5.512.993
2023-02-03 2023-02-01 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 6,9500 -40.000 -278 5.562.993
2023-02-01 2023-01-31 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 7,0800 -30.000 -212 5.602.993
2023-02-01 2023-01-30 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 6,9100 -30.000 -207 5.632.993
2023-01-27 2023-01-25 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 6,8500 -50.000 -342 5.662.993
2023-01-25 2023-01-24 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 6,9800 -80.000 -558 5.712.993
2023-01-25 2023-01-23 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 6,8100 -80.000 -545 5.792.993
2023-01-19 2023-01-17 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 6,7900 -6.114 -42 5.872.993
2023-01-17 2023-01-13 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 7,1500 -1.971 -14 5.879.107
2023-01-17 2023-01-12 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 6,7700 -5.000 -34 5.881.078
2023-01-11 2022-10-18 5 Morningside Venture Investments Ltd KZR Common Stock G - Gift D -120.000 5.931.740
2023-01-09 2023-01-06 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 6,8900 -3.000 -21 5.886.078
2023-01-09 2023-01-05 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 6,9700 -12.162 -85 5.889.078
2023-01-05 2023-01-04 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 7,1700 -30.000 -215 5.901.240
2023-01-05 2023-01-03 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 7,1000 -500 -4 5.931.240
2023-01-05 2022-12-29 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 7,1000 -25.000 -178 5.931.740
2022-11-14 2022-11-10 4 Fowler John Franklin KZR Common Stock M - Exercise D 0,9000 27.000 24 393.904
2022-10-05 2022-10-04 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 8,8199 -3.612 -32 6.076.740
2022-10-05 2022-10-03 4 Morningside Venture Investments Ltd KZR Common Stock S - Sale D 8,7790 -28.700 -252 6.080.352
2022-06-27 2022-06-23 4 Kirk Christopher J. KZR Common Stock M - Exercise D 0,9000 33.060 30 381.484
2022-05-13 2022-05-12 4 COOPER GRAHAM K KZR Stock Option (right to buy) A - Award D 5,52 26.000 26.000
2022-03-22 2022-03-21 4 BERGER FRANKLIN M KZR Common Stock P - Purchase D 14,7700 20.000 295 890.691
2022-03-22 2022-03-18 4 BERGER FRANKLIN M KZR Common Stock P - Purchase D 17,0000 45.000 765 870.691
2022-03-22 2022-03-18 4 BERGER FRANKLIN M KZR Common Stock P - Purchase D 15,9600 15.000 239 825.691
2022-01-07 2022-01-05 4 Henig Noreen KZR Employee Stock Option (right to buy) A - Award D 14,55 180.000 180.000
2022-01-07 2022-01-05 4 Fowler John Franklin KZR Employee Stock Option (right to buy) A - Award D 14,55 500.000 500.000
2022-01-07 2022-01-05 4 Kirk Christopher J. KZR Employee Stock Option (right to buy) A - Award D 14,55 170.000 170.000
2022-01-07 2022-01-05 4 Belsky Marc KZR Employee Stock Option (right to buy) A - Award D 14,55 140.000 140.000
2022-01-05 2022-01-03 4 Kauffman Michael KZR Stock Option (Right to Buy) M - Exercise D 5,91 -5.000 3.896
2022-01-05 2022-01-03 4 Kauffman Michael KZR Common Stock S - Sale D 16,4500 -5.000 -82 63.690
2022-01-05 2022-01-03 4 Kauffman Michael KZR Common Stock M - Exercise D 5,9100 5.000 30 68.690
2021-12-15 2021-12-14 4 Fowler John Franklin KZR Employee Stock Option (Right to Buy) M - Exercise D 0,90 -7.700 82.721
2021-12-15 2021-12-14 4 Fowler John Franklin KZR Common Stock M - Exercise D 0,9000 7.700 7 366.904
2021-12-10 2021-12-09 4 Wallace Courtney KZR Stock Option (right to buy) A - Award D 13,87 52.000 52.000
2021-09-23 2021-09-22 4 BERGER FRANKLIN M KZR Stock Option (Right to Buy) M - Exercise D 5,60 -8.896 0
2021-09-23 2021-09-22 4 BERGER FRANKLIN M KZR Common Stock M - Exercise D 5,6000 8.896 50 810.691
2021-09-23 2021-09-21 4 BERGER FRANKLIN M KZR Stock Option (Right to Buy) M - Exercise D 7,63 -8.896 0
2021-09-23 2021-09-21 4 BERGER FRANKLIN M KZR Stock Option (Right to Buy) M - Exercise D 5,91 -8.896 0
2021-09-23 2021-09-21 4 BERGER FRANKLIN M KZR Common Stock M - Exercise D 7,6300 8.896 68 801.795
2021-09-23 2021-09-21 4 BERGER FRANKLIN M KZR Common Stock M - Exercise D 5,9100 8.896 53 792.899
2021-06-30 2021-06-28 4 Sommadossi Jean-Pierre KZR Stock Option (Right to Buy) A - Award D 5,59 26.000 26.000
2021-06-30 2021-06-28 4 Kauffman Michael KZR Stock Option (Right to Buy) A - Award D 5,59 26.000 26.000
2021-06-30 2021-06-28 4 Klearman Micki KZR Stock Option (Right to Buy) A - Award D 5,59 26.000 26.000
2021-06-30 2021-06-28 4 Dinges Jason KZR Stock Option (Right to Buy) A - Award D 5,59 26.000 26.000
2021-06-30 2021-06-28 4 Garner Elizabeth KZR Stock Option (Right to Buy) A - Award D 5,59 26.000 26.000
2021-06-30 2021-06-28 4 BERGER FRANKLIN M KZR Stock Option (Right to Buy) A - Award D 5,59 26.000 26.000
2021-06-30 2021-06-28 4 COOPER GRAHAM K KZR Stock Option (Right to Buy) A - Award D 5,59 26.000 26.000
2021-06-03 2021-06-01 4 Klearman Micki KZR Stock Option (right to buy) A - Award D 5,94 52.000 52.000
2021-03-29 2019-05-30 4 Economides Vassiliki KZR Common Stock P - Purchase D 10,1900 750 8 11.320
2021-01-11 2021-01-08 4 Kirk Christopher J. KZR Employee Stock Option (right to buy) A - Award D 5,45 260.000 260.000
2021-01-11 2021-01-08 4 Henig Noreen KZR Employee Stock Option (right to buy) A - Award D 5,45 280.000 280.000
2021-01-11 2021-01-08 4 Fowler John Franklin KZR Employee Stock Option (right to buy) A - Award D 5,45 1.200.000 1.200.000
2021-01-11 2021-01-08 4 Economides Vassiliki KZR Employee Stock Option (right to buy) A - Award D 5,45 110.000 110.000
2021-01-11 2021-01-08 4 Belsky Marc KZR Employee Stock Option (right to buy) A - Award D 5,45 220.000 220.000
2021-01-04 2020-12-31 4 Fowler John Franklin KZR Employee Stock Option (Right to Buy) M - Exercise D 0,90 -16.000 90.421
2021-01-04 2020-12-31 4 Fowler John Franklin KZR Common Stock M - Exercise D 0,9000 16.000 14 359.204
2020-06-26 2020-06-24 4 Dinges Jason KZR Stock Option (Right to Buy) A - Award D 5,60 8.896 8.896
2020-06-26 2020-06-24 4 COOPER GRAHAM K KZR Stock Option (Right to Buy) A - Award D 5,60 8.896 8.896
2020-06-26 2020-06-24 4 Kauffman Michael KZR Stock Option (Right to Buy) A - Award D 5,60 8.896 8.896
2020-06-26 2020-06-24 4 BERGER FRANKLIN M KZR Stock Option (Right to Buy) A - Award D 5,60 8.896 8.896
2020-06-26 2020-06-24 4 Sommadossi Jean-Pierre KZR Stock Option (Right to Buy) A - Award D 5,60 8.896 8.896
2020-06-26 2020-06-24 4 Garner Elizabeth KZR Stock Option (Right to Buy) A - Award D 5,60 8.896 8.896
2020-06-15 2020-06-11 4 Equal Talent Investments Ltd KZR Common Stock P - Purchase D 5,5000 1.454.545 8.000 6.254.545
2020-06-11 2020-06-11 4 BERGER FRANKLIN M KZR Common Stock P - Purchase D 5,5000 100.000 550 784.003
2020-05-04 2020-05-01 4 Henig Noreen KZR Employee Stock Option (right to buy) A - Award D 4,56 300.000 300.000
2020-02-06 2020-02-04 4 Morningside Venture Investments Ltd KZR Common Stock P - Purchase D 2,6000 3.800.000 9.880 6.109.052
2020-02-06 3 Equal Talent Investments Ltd KZR Common Stock D 9.600.000
2020-02-06 3 Equal Talent Investments Ltd KZR Common Stock D 9.600.000
2020-02-06 3 Equal Talent Investments Ltd KZR Common Stock D 9.600.000
2020-02-05 2020-02-04 4 Fowler John Franklin By Montebello Holdings LLC KZR Common Stock P - Purchase I 2,6000 38.461 100 38.461
2020-02-05 2020-02-04 4 Kirk Christopher J. KZR Common Stock P - Purchase D 2,6000 38.461 100 342.609
2020-02-05 2020-02-04 4 BERGER FRANKLIN M KZR Common Stock P - Purchase D 2,6000 120.846 314 684.003
2020-02-05 2020-02-04 4 Economides Vassiliki KZR Common Stock P - Purchase D 2,6000 5.769 15 7.570
2020-02-05 2020-02-04 4 Belsky Marc KZR Common Stock P - Purchase D 2,6000 15.384 40 15.384
2020-01-13 2020-01-12 4 Belsky Marc KZR Employee Stock Option (right to buy) A - Award D 3,29 90.000 90.000
2020-01-13 2020-01-12 4 Fowler John Franklin KZR Employee Stock Option (right to buy) A - Award D 3,29 200.000 200.000
2020-01-13 2020-01-12 4 Kirk Christopher J. KZR Employee Stock Option (right to buy) A - Award D 3,29 125.000 125.000
2020-01-13 2020-01-12 4 Economides Vassiliki KZR Employee Stock Option (right to buy) A - Award D 3,29 62.500 62.500
2019-12-20 2019-12-19 4 Fowler John Franklin KZR Employee Stock Option (Right to Buy) M - Exercise D 0,90 -50.000 106.421
2019-12-20 2019-12-19 4 Fowler John Franklin KZR Common Stock M - Exercise D 0,9000 50.000 45 346.954
2019-12-19 2019-12-18 4 Garner Elizabeth KZR Stock Option (right to buy) A - Award D 3,03 17.793 17.793
2019-11-13 2019-11-13 4 Belsky Marc By Trust KZR Common Stock P - Purchase I 2,7588 800 2 2.000
2019-10-11 2019-10-10 4 Fowler John Franklin By Trust KZR Common Stock P - Purchase I 3,2354 1.000 3 296.954
2019-09-10 2019-09-06 4 Belsky Marc KZR Employee Stock Option (right to buy) A - Award D 3,38 60.000 60.000
2019-09-10 2019-09-06 4 Economides Vassiliki KZR Employee Stock Option (right to buy) A - Award D 3,38 35.000 35.000
2019-08-21 2019-08-20 4 Belsky Marc By Trust KZR Common Stock P - Purchase I 4,4200 200 1 1.200
2019-08-21 2019-08-20 4 Economides Vassiliki KZR Common Stock P - Purchase D 4,4102 350 2 1.801
2019-08-15 2019-08-13 4 Kirk Christopher J. KZR Common Stock P - Purchase D 4,6080 5.000 23 302.934
2019-08-14 2019-08-13 4 Fowler John Franklin By Trust KZR Common Stock P - Purchase I 4,6550 2.000 9 295.954
2019-08-12 2019-08-09 4 Kirk Christopher J. KZR Common Stock P - Purchase D 4,9660 5.000 25 297.934
2019-08-12 2019-08-09 4 Belsky Marc By Trust KZR Common Stock P - Purchase I 4,8200 500 2 1.000
2019-08-12 2019-08-09 4 Economides Vassiliki KZR Common Stock P - Purchase D 4,9582 1.020 5 1.451
2019-08-12 2019-08-09 4 Fowler John Franklin By Trust KZR Common Stock P - Purchase I 5,0147 750 4 293.954
2019-08-12 2019-08-09 4 Fowler John Franklin KZR Common Stock P - Purchase D 5,2550 500 3 293.204
2019-07-26 2019-07-26 4 Belsky Marc By Trust KZR Common Stock P - Purchase I 5,8000 56 0 500
2019-07-26 2019-07-25 4 Belsky Marc By Trust KZR Common Stock P - Purchase I 5,6540 444 3 444
2019-07-23 2019-07-22 4 Economides Vassiliki KZR Common Stock P - Purchase D 5,8207 431 3 431
2019-06-27 2019-06-25 4 Sommadossi Jean-Pierre KZR Stock Option (Right to Buy) A - Award D 7,63 8.896 8.896
2019-06-27 2019-06-25 4 Dinges Jason KZR Stock Option (Right to Buy) A - Award D 7,63 8.896 8.896
2019-06-27 2019-06-25 4 Kauffman Michael KZR Stock Option (Right to Buy) A - Award D 7,63 8.896 8.896
2019-06-27 2019-06-25 4 BERGER FRANKLIN M KZR Stock Option (Right to Buy) A - Award D 7,63 8.896 8.896
2019-06-27 2019-06-25 4 COOPER GRAHAM K KZR Stock Option (Right to Buy) A - Award D 7,63 8.896 8.896
2019-03-06 2019-03-04 4 Economides Vassiliki KZR Employee Stock Option (right to buy) A - Award D 20,25 70.000 70.000
2019-01-08 2019-01-06 4 Belsky Marc KZR Employee Stock Option (right to buy) A - Award D 22,85 60.000 60.000
2019-01-08 2019-01-06 4 Fowler John Franklin KZR Employee Stock Option (right to buy) A - Award D 22,85 175.000 175.000
2019-01-08 2019-01-06 4 Goel Niti KZR Employee Stock Option (right to buy) A - Award D 22,85 75.000 75.000
2019-01-08 2019-01-06 4 Kirk Christopher J. KZR Employee Stock Option (right to buy) A - Award D 22,85 87.500 87.500
2018-07-05 2018-06-25 4 STEYER THOMAS F By revocable trust KZR Series B Convertible Preferred Stock C - Conversion I -125.927 0
2018-07-05 2018-06-25 4 STEYER THOMAS F By revocable trust KZR Series A Convertible Preferred Stock C - Conversion I -210.326 0
2018-07-05 2018-06-25 4 STEYER THOMAS F By revocable trust KZR Common Stock C - Conversion I 125.927 125.927
2018-07-05 2018-06-25 4 STEYER THOMAS F By revocable trust KZR Common Stock C - Conversion I 210.326 210.326
2018-06-28 2018-06-25 4 BAY CITY CAPITAL LLC See Footnotes KZR Series B Redeemable Convertible Preferred Stock C - Conversion I -472.229 0
2018-06-28 2018-06-25 4 BAY CITY CAPITAL LLC See Footnotes KZR Common Stock P - Purchase I 15,0000 150.000 2.250 622.229
2018-06-28 2018-06-25 4 BAY CITY CAPITAL LLC See Footnotes KZR Common Stock C - Conversion I 472.229 472.229
2018-06-27 2018-06-25 4 Cormorant Asset Management, LLC KZR Series B Redeemable Convertible Preferred Stock C - Conversion D -1.007.421 0
2018-06-27 2018-06-25 4 Cormorant Asset Management, LLC KZR Series A Redeemable Convertible Preferred Stock C - Conversion D -315.488 0
2018-06-27 2018-06-25 4 Cormorant Asset Management, LLC See Footnotes KZR Common Stock P - Purchase I 15,0000 250.000 3.750 1.572.909
2018-06-27 2018-06-25 4 Cormorant Asset Management, LLC See Footnotes KZR Common Stock C - Conversion I 1.007.421 1.322.909
2018-06-27 2018-06-25 4 Cormorant Asset Management, LLC KZR Common Stock C - Conversion I 315.488 315.488
2018-06-27 2018-06-25 4 Aberdare Management Company, LLC KZR Series B Convertible Preferred Stock C - Conversion D -31.481 0
2018-06-27 2018-06-25 4 Aberdare Management Company, LLC KZR Series A Convertible Preferred Stock C - Conversion D -105.162 0
2018-06-27 2018-06-25 4 Aberdare Management Company, LLC KZR Common Stock C - Conversion D 31.481 136.643
2018-06-27 2018-06-25 4 Aberdare Management Company, LLC KZR Common Stock C - Conversion D 105.162 105.162
2018-06-27 2018-06-25 4 BERGER FRANKLIN M KZR Series B Convertible Preferred Stock C - Conversion D -197.076 0
2018-06-27 2018-06-25 4 BERGER FRANKLIN M KZR Series A Convertible Preferred Stock C - Conversion D -262.907 0
2018-06-27 2018-06-25 4 BERGER FRANKLIN M KZR Common Stock P - Purchase D 15,0000 50.000 750 563.157
2018-06-27 2018-06-25 4 BERGER FRANKLIN M KZR Common Stock C - Conversion D 197.076 513.157
2018-06-27 2018-06-25 4 BERGER FRANKLIN M KZR Common Stock C - Conversion D 262.907 316.081
2018-06-27 2018-06-25 4 Fowler John Franklin KZR Employee Stock Option (Right to Buy) A - Award D 5,91 88.967 88.967
2018-06-27 2018-06-25 4 Kauffman Michael KZR Series A Convertible Preferred Stock C - Conversion D -10.516 0
2018-06-27 2018-06-25 4 Kauffman Michael KZR Common Stock C - Conversion D 10.516 63.690
2018-06-27 2018-06-25 4 Kirk Christopher J. KZR Employee Stock Option (Right to Buy) A - Award D 5,91 26.690 26.690
2018-06-27 2018-06-25 4 Morningside Venture Investments Ltd KZR Series B Convertible Preferred Stock C - Conversion D -1.007.422 0
2018-06-27 2018-06-25 4 Morningside Venture Investments Ltd KZR Series A Convertible Preferred Stock C - Conversion D -1.051.630 0
2018-06-27 2018-06-25 4 Morningside Venture Investments Ltd KZR Common Stock P - Purchase D 15,0000 250.000 3.750 2.309.052
2018-06-27 2018-06-25 4 Morningside Venture Investments Ltd KZR Common Stock C - Conversion D 1.007.422 2.059.052
2018-06-27 2018-06-25 4 Morningside Venture Investments Ltd KZR Common Stock C - Conversion D 1.051.630 1.051.630
2018-06-27 2018-06-25 4 Sommadossi Jean-Pierre By JPM Partners, LLC KZR Series B Convertible Perferred Stock C - Conversion I -35.258 0
2018-06-27 2018-06-25 4 Sommadossi Jean-Pierre By JPM Partners, LLC KZR Series A Convertible Perferred Stock C - Conversion I -52.581 0
2018-06-27 2018-06-25 4 Sommadossi Jean-Pierre By JPM Partners, LLC KZR Common Stock C - Conversion I 35.258 178.440
2018-06-27 2018-06-25 4 Sommadossi Jean-Pierre By JPM Partners, LLC KZR Common Stock C - Conversion I 52.581 143.182
2018-06-26 2018-06-25 4 PAPPAS ARTHUR M See footnotes KZR Series B Preferred Stock, par value $0.001 per share C - Conversion I 23.894 0
2018-06-26 2018-06-25 4 PAPPAS ARTHUR M See footnotes KZR Series B Preferred Stock, par value $0.001 per share C - Conversion I 290.924 0
2018-06-26 2018-06-25 4 PAPPAS ARTHUR M See footnotes KZR Common Stock, par value $0.001 per share C - Conversion I 23.894 23.894
2018-06-26 2018-06-25 4 PAPPAS ARTHUR M See footnotes KZR Common Stock, par value $0.001 per share C - Conversion I 290.924 290.924
2018-06-26 2018-06-25 4 Chiesi Ventures, Inc. KZR Series B Preferred Stock, par value $0.001 per share C - Conversion I 314.819 0
2018-06-26 2018-06-25 4 Chiesi Ventures, Inc. KZR Common Stock, par value $0.001 per share C - Conversion I 314.819 314.819
2018-06-25 2018-06-25 4 Onyx Therapeutics, Inc. KZR Series A Redeemable Convertible Preferred Stock C - Conversion D -1.121.384 0
2018-06-25 2018-06-25 4 Onyx Therapeutics, Inc. KZR Common Stock C - Conversion D 1.121.384 1.121.384
2018-06-25 2018-06-25 4 Omega Fund IV, L.P. KZR Series B Redeemable Convertible Preferred Stock C - Conversion D -377.783 0
2018-06-25 2018-06-25 4 Omega Fund IV, L.P. By Omega IV KZR Series B Redeemable Convertible Preferred Stock C - Conversion I -377.783 0
2018-06-25 2018-06-25 4 Omega Fund IV, L.P. KZR Series A Redeemable Convertible Preferred Stock C - Conversion D -315.489 0
2018-06-25 2018-06-25 4 Omega Fund IV, L.P. By Omega IV KZR Series A Redeemable Convertible Preferred Stock C - Conversion I -315.489 0
2018-06-25 2018-06-25 4 Omega Fund IV, L.P. By Omega IV KZR Common Stock C - Conversion I 377.783 693.272
2018-06-25 2018-06-25 4 Omega Fund IV, L.P. KZR Common Stock C - Conversion D 377.783 693.272
2018-06-25 2018-06-25 4 Omega Fund IV, L.P. KZR Common Stock C - Conversion D 315.489 315.489
2018-06-25 2018-06-25 4 Omega Fund IV, L.P. By Omega IV KZR Common Stock C - Conversion I 315.489 315.489
2018-06-20 3 Kauffman Michael KZR Common Stock D 106.348
2018-06-20 3 Kauffman Michael KZR Common Stock D 106.348
2018-06-20 3 Kauffman Michael KZR Common Stock D 106.348
2018-06-20 3 Kirk Christopher J. KZR Common Stock D 585.408
2018-06-20 3 Kirk Christopher J. KZR Common Stock D 585.408
2018-06-20 3 Kirk Christopher J. KZR Common Stock D 585.408
2018-06-20 3 Sommadossi Jean-Pierre By JPM Partners, LLC KZR Common Stock I 181.202
2018-06-20 3 Sommadossi Jean-Pierre By JPM Partners, LLC KZR Common Stock I 181.202
2018-06-20 3 Sommadossi Jean-Pierre By JPM Partners, LLC KZR Common Stock I 181.202
2018-06-20 3 BERGER FRANKLIN M KZR Common Stock D 106.348
2018-06-20 3 BERGER FRANKLIN M KZR Common Stock D 106.348
2018-06-20 3 BERGER FRANKLIN M KZR Common Stock D 106.348
2018-06-20 3 Fowler John Franklin KZR Common Stock D 585.408
2018-06-20 3 Fowler John Franklin KZR Common Stock D 585.408
2018-06-20 3 Fowler John Franklin KZR Common Stock D 585.408
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Other Listings
DE:2KZ0 6,15 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista